FCMI
Foresite Capital Management III Portfolio holdings
AUM
$37.9M
This Quarter Return
-22.83%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$32.8M
AUM Growth
+$32.8M
(-17%)
Cap. Flow
+$2.77M
Cap. Flow
% of AUM
8.45%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
–
Closed
–
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$11.8B
| $15.7M | 47.81% | 133,691 | – | – |
|
2
Natera
NTRA
$23.1B
| $6.48M | 19.73% | 159,160 +68,160 | +75% | +$2.77M |
|
|
VRNA
3
Verona Pharma
VRNA
$9.16B
| $5.54M | 16.89% | 1,111,112 | – | – |
|
|
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
| $5.11M | 15.56% | 1,641,804 | – | – |
|